---
title: "Pacira BioSciences SVP Finance Lauren Riker disposes of 6,000 common shares worth $217,920"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301445821.md"
description: "Pacira BioSciences SVP of Finance Lauren Riker disposed of 6,000 common shares worth $217,920. On October 8, 2026, she exercised stock options for 6,000 shares at $32.35 and immediately sold them at $36.32. Following these transactions, her directly held common stock position stands at 62,284 shares."
datetime: "2026-10-09T23:08:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301445821.md)
  - [en](https://longbridge.com/en/news/301445821.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301445821.md)
generator: "portal-rs"
---

# Pacira BioSciences SVP Finance Lauren Riker disposes of 6,000 common shares worth $217,920

-   Pacira BioSciences SVP, Finance Lauren Riker exercised stock options for 6,000 shares at $32.35 on Oct. 8, 2026. \* Riker sold 6,000 shares at $36.32 on the same day. \* Directly held common stock position stood at 62,284 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065566), on October 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PCRX.US](https://longbridge.com/en/quote/PCRX.US.md)

## Related News & Research

- [SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)](https://longbridge.com/en/news/301512102.md)
- [HC Wainwright & Co. downgrades Pacira BioSciences to Neutral, sets price target to $36.50](https://longbridge.com/en/news/301393942.md)
- [Intel Corporation $INTC Shares Purchased by Baugh & Associates LLC](https://longbridge.com/en/news/302172058.md)
- [Viatris agrees to buy Pacira BioSciences for $36.50 a share in cash, valuing deal at $1.65 billion](https://longbridge.com/en/news/301270461.md)
- [Billionaires Are Selling These 6 Artificial Intelligence (AI) Stocks. Should You Follow?](https://longbridge.com/en/news/302092492.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**